1. Home
  2. HAS vs CORT Comparison

HAS vs CORT Comparison

Compare HAS & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

HAS

Hasbro Inc.

N/A

Current Price

$92.53

Market Cap

13.3B

ML Signal

N/A

Logo Corcept Therapeutics Incorporated

CORT

Corcept Therapeutics Incorporated

N/A

Current Price

$111.62

Market Cap

9.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HAS
CORT
Founded
1923
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Recreational Games/Products/Toys
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.3B
9.7B
IPO Year
1994
2001

Fundamental Metrics

Financial Performance
Metric
HAS
CORT
Price
$92.53
$111.62
Analyst Decision
Strong Buy
Buy
Analyst Count
11
5
Target Price
$109.73
$96.50
AVG Volume (30 Days)
1.2M
731.0K
Earning Date
05-20-2026
04-30-2026
Dividend Yield
2.98%
N/A
EPS Growth
N/A
N/A
EPS
2.51
0.09
Revenue
$5,365,900,000.00
$761,407,000.00
Revenue This Year
$5.38
$26.08
Revenue Next Year
$6.48
$26.98
P/E Ratio
$36.94
$1,269.56
Revenue Growth
13.06
12.79
52 Week Low
$69.50
$28.66
52 Week High
$106.98
$126.38

Technical Indicators

Market Signals
Indicator
HAS
CORT
Relative Strength Index (RSI) 49.00 54.11
Support Level $92.09 $77.73
Resistance Level $94.35 $124.30
Average True Range (ATR) 1.91 4.38
MACD -0.60 -1.79
Stochastic Oscillator 11.31 31.35

Price Performance

Historical Comparison
HAS
CORT

About HAS Hasbro Inc.

Hasbro is a branded play company providing children and families around the world with entertainment offerings based on a world-class brand portfolio. From toys and games to television programming, motion pictures, and a licensing program, Hasbro reaches customers by leveraging its well-known brands such as Transformers, Peppa Pig, and Magic: The Gathering. The firm acquired EOne in 2019, bolting on popular family properties like Peppa Pig and PJ Masks, and has since divested noncore lines from the tie-up. Furthermore, the addition of Dungeons & Dragons Beyond in 2022 offers the firm access to around 20 million digital tabletop players.

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic, and neuropsychiatric disorders by modulating the effect of the cortisol hormone. The company markets Korlym (mifepristone) tablets and its authorized generic version, which is an oral medication for the treatment of hypercortisolism (also known as Cushing's syndrome). Additionally, its pipeline contains several key compounds, such as Relacorilant, Dazucorilant, Miricorilant, etc., that are being evaluated in clinical trials as potential treatments for a variety of serious disorders like hypercortisolism, solid tumors (including ovarian, endometrial, cervical, pancreatic, and prostate cancers), ALS, and MASH.

Share on Social Networks: